“Sell in May and go away” is a popular investor saying.

Investors who follow it sell their stocks in May and wait to reinvest after the “underperforming” summer months have passed.

However, this is anything but a typical stock market.

In today’s episode of The Bull & The Bear, chief investment strategist Adam O’Dell and I tell you what the past few years of investing history might mean for today’s markets.

Should You “Sell in May and Go Away?”

If we’ve seen anything in this latest market, it’s that anything can happen.

Yes, we can use historical trends to help predict future market movements, but no one has a crystal ball.

S&P 500 Average Returns Don’t Provide Clear Direction

The idea of “sell in May and go away” indicates weaker stock performance during the summer months.

However, from 2018 to now, the numbers tell a different story.

But what does all that mean for investors?

In this episode of The Bull & The Bear, we’ll dive deeper into that question and tell you how you should approach the summer months with your investments.

The Bull & The Bear

Led by Adam O’Dell and a team of finance journalists, traders and experts, Money & Markets gives you the information you need to protect your nest egg, grow your wealth and safeguard your financial well-being.

You can listen to The Bull & The Bear on Apple PodcastsSpotifyAmazon and Google Podcasts. Make sure to subscribe and leave us a review.

Be sure to also subscribe to our YouTube channel for more videos like my weekly Marijuana Market Update.

Have something you want us to talk about? Email thebullandthebear@moneyandmarkets.com and give us your thoughts.

Check out moneyandmarkets.com, and sign up for our free newsletters that deliver you the most important and unbiased financial news, commentary, and actionable advice.

Also, follow us on:

Safe trading,


Matt Clark
Research Analyst, Money & Markets

Matt Clark is the research analyst for Money & Markets. He’s the host of our podcast, The Bull & The Bear, as well as the Marijuana Market Update. Before joining the team, he spent 25 years as an investigative journalist and editor — covering everything from politics to business.

P.S. Chief investment strategist Adam O’Dell is bullish on biotech. He just revealed his next biotech stock recommendation in May’s monthly Green Zone Fortunes issue. I urge you to check out Adam’s presentation on what he calls “Imperium.” He's confident this DNA trend has the potential to be bigger than internet stocks in the ’90s. Click here to find out more. If you subscribe to Green Zone Fortunes today, you’ll find out how to get in on the ground floor with Adam's next biotech recommendation.